Sputnik V COVID-19 vaccine launched in India by Dr Reddy’s
pharmafile | May 17, 2021 | News story | Sales and Marketing |
Dr Reddy’s Laboratories has begun vaccinating in India with Russia’s COVID-19 vaccine as part of its soft launch after it obtained regulatory clearance from the Kolkata-based Central Drugs Laboratory.
The vaccine, Sputnik V, received an emergency use authorisation in India in April.
The first phase of the programme started with vaccinations in Hyderabad, and will commence in Visakhapatnam on Tuesday at Apollo Hospitals in those cities. The vaccinations would follow the SOPs recommended by the Indian government, including registration on CoWIN.
This pilot phase allows Dr Reddy’s and Apollo to test the arrangements and cold-chain logistics, and prepare for the launch.
After Hyderabad and Visakhapatnam, the pilot programme will be extended to Delhi, Mumbai, Bengaluru, Ahmedabad, Chennai, Kolkata, and Pune.
Dr K Hari Prasad, President, Hospitals Division, Apollo Hospitals said, “With the opening up of the vaccination programme for the private sector, we have intensified our efforts to accelerate the rate of vaccination by opening vaccination centres across our hospital network and are also in discussions with corporates to undertake vaccination on their premises.
“We are currently administering COVID vaccines at 60 locations across the country, including Apollo Hospitals, Apollo Spectra Hospitals, and Apollo Clinics.”
Dr Reddy’s Laboratories Co-Chairman and Managing Director G V Prasad said: “With the rising cases in India, vaccination is our most effective tool in our battle against COVID-19.
“Contributing to the vaccination drive in India is our biggest priority right now to help Indians be healthy and safe.”
Sauri Gudavalli, Head of R&D, Dr Reddy’s said, “The plan is to import about 15-18 million doses of vaccines from Russia initially. And, thereafter, within a month or two, domestic manufacturers will be able to produce locally.”
This news follows India recording its highest ever death total in a single day and as the federal government pledges to bolster vaccine supplies.